For strategy, business unit and technical leaders
Turn the growth number into a plan your CFO will sign
You're not short of ideas. What’s hard is deciding between them, and the evidence to back the call. EVOS gives you both.
Three questions most growth plans can't answer
What share of last year's revenue came from products launched last year?
When two projects last competed for the same engineers, what settled it?
Can you show next year's growth broken into products, customers and dates?
If any of these was hard, EVOS was built for you.
What changes when the plan lives in one place
| Before | With EVOS |
|---|---|
| Growth decks rebuilt every quarter | One live model: goal, gap, bets and dates |
| Customer insight lives in one person's notes | Every call and field report becomes a record anyone can act on |
| Projects justified one status update at a time | Each project carries its goal, timing, upside and share of the gap |
| M&A and organic growth reviewed separately | Build, buy and partner compared against the same goal |
| Years four and five are guesswork | Long programs get a latest start date and a re-plan trigger |
From growth target to approved roadmap
- Set the destination.Enter the growth goal, horizon and CAGR. EVOS shows the gap your current products leave, year by year.
- Load your market.Paste in company URLs, upload customer calls and notes. EVOS maps the players, products, patents and pain points.
- Score and size.See where your capabilities, real market pain and ready technology overlap, then size each bet bottom-up.
- Decide and track.Approve a scenario plan. Signals keeps every bet current and tells you when the evidence moves.
Placeholder: a small screenshot beside each step.
Built for the four people every growth decision needs
The champion (strategy or technical lead)
A case a former CFO will sign: risk, investment, return and timing.
The business unit head
Scope inside the budget they already control, with a first result this year.
The CEO and CFO
Growth as an investment, never a cost, with the price of delay in plain numbers.
IT and legal
Deployment in your own cloud, to your security requirements, with an audit trail on every record.
Built for technical companies
We pointed the method at Roche's public record. It called the revenue mix seven years early.
Half of Roche Pharmaceuticals' revenue was heading off patent. The pipeline evidence already showed what would replace it.
Start with one product line
Pick the product line or market that matters most this year. We'll load it before the demo and show you its gap.